Login

The pandemic accelerated our focus on operational resilience and digital transformation. 00:10:00

Share On Facebook Share On Twitter

Doron Blachar is Chief Executive Officer, Ormat Technologies Inc.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Flowery Branch Council Approves Phase Two Planning with Parkside Partners
00:10:00
Parfit: A Philosopher's Quest for Moral Objectivity|David Edmonds,Professor,BBC World Service
00:10:00
Fee-Only Financial Advisor: Personalized Planning for Stress-Free Retirement
00:10:00
Exploring the Future of Drug Development|Vineeta Agarwala,General Partner,Andreessen Horowitz
00:10:00
Exploring the Transition from Hollywood to Anti-Aging: Insights from a Former Columbia Pictures Executive Turned Nutraceutical CEO | Robert Fried ,CEO, Chromadex Corp.
00:10:00
South American Company Successfully Weathers Crisis, CEO Oscar Hasbún Affirms | Oscar Hasbún Martínez - CEO of CSAV
00:10:00
John Rogers of Ariel Investments: From Founding at 24 to Insights on Investing and Life
00:00:00
Interview with Dan Mogren, CEO - Clinical Laserthermia Systems
00:10:00
How ETFs Work: Understanding the iNAV Concept and Key Considerations | Gaurav Jain, Co-Founder & Investment Educator, Yadnya Investment Academy
00:10:00
Mastering Financial Planning Interviews: Key Qualities and Strategies
00:00:00
Jesper Söderqvist, CEO, Boule Diagnostics
00:10:00
Supriya Lifescience Limited Earnings Review & Business Outlook by Director Saloni Wagh | Saloni Wagh, Director, Supriya Lifescience Limited.

© 2026 Nehu